Chart of Day: Revisiting Viking Therapeutics (VKTX) – 3/21

When we first mentioned Viking Therapeutics (VKTX) with the Chart of Day, it traded at around $35 a share on February 20. By March 5, it was above $92 a share.

Today, after slipping to $66.72 on competitor trial news, VKTX is starting to push higher again.

Last trading at $66.72, we’d like to see it challenge $92 again shortly.


VKTX recently announced Phase 2 data for their obesity drug. After just 13 weeks, 35 patients titrated up to 15 mg of once-weekly VK2735 lost 14.7% of their baseline weight, a 13.1% improvement over placebo. 

There’s also speculation VKTX could be an acquisition target.

Working much like Eli Lilly’s Mounjaro, which stimulates GLP-1 and GIP, VKTX’s treatment triggers a feeling of fulness in the body after eating, which then leads to weight loss. 

We also have to remember that the obesity story is bursting at the seams. According to the World Health Organization, obesity has tripled since 1975.  More than 1.9 billion adults were overweight as of 2016, with more than 650 million considered obese. Plus, more than 340 million children were considered overweight in 2016, as well.  

At the rate we’re going, obesity will be the downfall of millions.

However, if millions of people can take a pill or get a shot to help lose weight, it could create an unbelievable multi-billion-dollar opportunity for stocks like VKTX.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.